Satsuma Pharmaceuticals (STSA) Stock Tumbles On Clinical Data

Satsuma Pharmaceuticals STSA Stock News

Satsuma Pharmaceuticals Inc (NASDAQ: STSA) is falling like a brick thrown from the Empire State Building this morning, and for good reason. The company released topline data from a Phase 3 study that missed the mark. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! STSA Stock Falls … Read more